DHB — Delivra Health Brands Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual income statement for Delivra Health Brands, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

	R2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7.78	7.96	8.14	9.79	12.4
Cost of Revenue
Gross Profit	1.52	2.91	3.38	5.22	6.64
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	65	29.8	14.3	10.3	11.2
Operating Profit	-57.2	-21.9	-6.18	-0.467	1.15
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-58.7	-22.7	-7.01	-0.184	0.876
Net Income After Taxes	-58.7	-22.7	-7.01	-0.184	0.876
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-79.9	-28.5	-7.01	-0.184	0.876
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-79.9	-28.5	-7.01	-0.184	0.876
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.67	-0.391	-0.213	-0.051	-0.024